Detalhe da pesquisa
1.
Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study.
Am J Transplant
; 17(5): 1370-1379, 2017 May.
Artigo
Inglês
| MEDLINE | ID: mdl-27862923
2.
Daclizumab Versus Rabbit Antithymocyte Globulin in High-Risk Renal Transplants: Five-Year Follow-up of a Randomized Study.
Am J Transplant
; 15(7): 1923-32, 2015 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-25707875
3.
COVID-19 epidemic phases: Criteria, challenges and issues for the future.
Bull Acad Natl Med
; 204(9): e145-e156, 2020 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-32836261
4.
[Covid-19 epidemic phases: Criteria, challenges and issues for the future]. / Les phases de l'épidémie du Covid-19 : critères, défis et enjeux pour le futur.
Bull Acad Natl Med
; 204(8): 748-760, 2020 Oct.
Artigo
Francês
| MEDLINE | ID: mdl-32836262
5.
Alefacept combined with tacrolimus, mycophenolate mofetil and steroids in de novo kidney transplantation: a randomized controlled trial.
Am J Transplant
; 13(7): 1724-33, 2013 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-23730730
6.
Long-term exposure to belatacept in recipients of extended criteria donor kidneys.
Am J Transplant
; 13(11): 2884-91, 2013 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-24103072
7.
Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients.
Am J Transplant
; 12(1): 210-7, 2012 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-21992533
8.
A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).
Am J Transplant
; 10(3): 535-46, 2010 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-20415897
9.
Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study.
Am J Transplant
; 10(12): 2632-43, 2010 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-20840480
10.
The challenge of preserving renal function after liver transplantation.
Panminerva Med
; 51(4): 249-55, 2009 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-20195235
11.
Prevention of calcineurin inhibitor nephrotoxicity in renal transplantation.
Transpl Immunol
; 20(1-2): 29-31, 2008 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-18817870
12.
Selective depression of the xenogeneic cell-mediated lympholysis in systemic lupus erythematosus.
J Clin Invest
; 64(2): 351-60, 1979 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-110833
13.
Absence of CD4CD25 regulatory T cell expansion in renal transplanted patients treated in vivo with Belatacept mediated CD28-CD80/86 blockade.
Transpl Immunol
; 17(4): 243-8, 2007 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-17493526
14.
Efficacy of Prolonged- and Immediate-release Tacrolimus in Kidney Transplantation: A Pooled Analysis of Two Large, Randomized, Controlled Trials.
Transplant Proc
; 49(9): 2040-2049, 2017 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-29149958
15.
Tolerability of enteric-coated mycophenolate sodium to 1 year in combination with cyclosporine and corticosteroids in renal transplant recipients.
Transplant Proc
; 38(9): 2860-3, 2006 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-17112849
16.
A dynamic in vivo view of the HIV-I Rev-RRE interaction.
J Mol Biol
; 266(5): 950-62, 1997 Mar 14.
Artigo
Inglês
| MEDLINE | ID: mdl-9086273
17.
The archaeal sRNA binding protein L7Ae has a 3D structure very similar to that of its eukaryal counterpart while having a broader RNA-binding specificity.
J Mol Biol
; 342(3): 757-73, 2004 Sep 17.
Artigo
Inglês
| MEDLINE | ID: mdl-15342235
18.
Hemolytic uremic syndrome. Recurrence after renal transplantation. Groupe Coopératif de l'Ile-de-France (GCIF).
Medicine (Baltimore)
; 79(2): 90-102, 2000 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-10771707
19.
Antibody-mediated endocytosis of G250 tumor-associated antigen allows targeted gene transfer to human renal cell carcinoma in vitro.
Cancer Gene Ther
; 6(6): 564-71, 1999.
Artigo
Inglês
| MEDLINE | ID: mdl-10608353
20.
Human growth hormone gene transfer into tumor cells may improve cancer chemotherapy.
Cancer Gene Ther
; 9(6): 497-504, 2002 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-12032660